Introduction: Cognitive dysfunction in schizophrenia

Acta Psychiatrica Scandinavica, Supplement

Volumn 104, Issue 408, 2001, Pages 5-9

  Lublin, H ^a  

^a Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; DOPAMINE 2 RECEPTOR;

ANTICHOLINERGIC EFFECT; ATTENTION; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; DISEASE ASSOCIATION; EDITORIAL; HUMAN; SCHIZOPHRENIA; WORKING MEMORY; ARTICLE; DRUG EFFECT; NEUROPSYCHOLOGICAL TEST; RATING SCALE;

ANTIPSYCHOTIC AGENTS; BRIEF PSYCHIATRIC RATING SCALE; CLOZAPINE; COGNITION DISORDERS; HUMAN; NEUROPSYCHOLOGICAL TESTS; RECEPTORS, DOPAMINE D2; SCHIZOPHRENIA;

EID: 0035233001     PISSN: 00651591     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (45)

1. Cognitive deficits in schizophrenia
2. Neuropsychological function in schizophrenia: Selective impairment in memory and learning
3. Dementia praecox oder der gruppe der schizophrenien
4. The performance of young schizophrenics and young normal controls on Wisconsin Cart Sorting Test
5. The generalized pattern of neuropsychological deficits in outpatients with chronic schizophrenia with heterogeneous Wisconsin Card Sorting Test results
6. Neuropsychological heterogeneity in schizophrenia: A consideration of abstraction and problem-solving abilities
7. Neurocognitive deficits in schizophrenia
8. Schizophrenic deficits in processing of context. A test of a theoretical model
9. Frontal lobe syndrome
10. Context, cortex and dopamine: A connectionist approach to behavior and biology in schizophrenia
11. Functional neuroanatomy of the limbic system and prefrontal cortex
12. Cognition and neuropathology in schizophrenia
13. Cognitive dysfunction in schizophrenia: A set of tools for the assessment of cognition and drug effects
14. The effect of neuroleptics on cognitive function
15. Psychomotor impairment and cognitive disturbances induced by neuroleptics
16. The effects of neuroleptics on neuropsychological test results of schizophrenics
17. Relation of neuroleptic and anticholinergic medication to cognitive function in schizophrenia
18. Neuroleptics: Effects on neuropsychological function in chronic schizophrenic patients
19. A continuous performance test of brain damage
20. Cognitive effects of conventional and atypical antipsychotics in schizophrenia
21. Characterization of typical and atypical antipsychotic drugs based on in vivo occupancy of serotonin 2 and dopamine 2 receptors
22. Cognitive function in schizophrenia: Do neuroleptics make a difference?
23. Contrasts between patients with affective disorder and patients with schizophrenia on a neuropsychological screening battery
24. The brief psychiatric rating scale
25. Mechanism of action of atypical antipsychotic drugs: An update
26. New antipsychotics. A review of their current status and clinical potential
27. Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine
28. Effects of clozapine on cognitive function in schizophrenia
29. The comparative effect of clozapine treatment on neuropsychological test performance
30. The effect of clozapine on symptom reduction, neurocognitive function, and clinical management in treatment-refractory state hospital schizophrenic inpatients
31. The effect of clozapine on cognitive function in treatment-resistant schizophrenic patients
32. The impact of clozapine on cognition and psychiatric symptoms in patients with schizophrenia
33. Does risperidone improve verbal working memory in treatment-resistant schizophrenia?
34. First episode schizophrenia: The importance of compliance and preserving cognitive function
35. Cognitive dysfunction in schizophrenia: Comparison of treatment with atypical antipsychotic agents and conventional neuroleptic drugs
36. Comparison of risperidone and clozapine on clinical functions in psychotic disorders
37. Neuropsychological change in early phase schizophrenia over twelve months of treatment with olanzapine, risperidone, or haloperidol
38. Cognitive dysfunction in schizophrenia and its importance to outcome: The place of atypical antipsychotics in treatment
39. Neuropsychiatric rehabilitation for persistent mental illness
40. Specific cognitive flexibility rehabilitation in schizophrenia
41. Cognitive impairment as a target for pharmacological treatment in schizophrenia
42. Treatment of cognitive dysfunctions and behavioral deficits in schizophrenia